Impact of bariatric surgery on renal functions in patients with type 2 diabetes: systematic review of randomized trials and observational studies

Surgery for Obesity and Related Diseases

Volumn 12, Issue 10, 2016, Pages 1873-1882

  Zhou, Xu ^a   Li, Ling ^a   Kwong, Joey S W ^a   Yu, Jiajie ^a   Li, Youping ^a   Sun, Xin ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Bariatric surgery; Renal functions; Systematic review; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; CREATININE;

ALBUMINURIA; ARTICLE; BARIATRIC SURGERY; COCHRANE LIBRARY; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EMBASE; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; URINARY EXCRETION; ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; MALE; MIDDLE AGED; OBESITY, MORBID; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADULT; ALBUMINURIA; BARIATRIC SURGERY; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85002857027     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.05.003     Document Type: Article

References (50)

1. [1] International Diabetes Federation. IDF diabetes atlas update 2015 [homepage on the Internet]. Brussels, Belgium: IDF; 2015 [cited 2016 Jan 10]. Available from: http://www.diabetesatlas.org/resources/2015-atlas.html.
2. [2] Bilous, R., Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?. Diabet Med 25:Suppl 2 (2008), 25–29.
3. [3] Gloy, V.L., Briel, M., Bhatt, D.L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, 347, 2013, f5934.
4. [4] Maggard-Gibbons, M., Maglione, M., Livhits, M., et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 309:21 (2013), 2250–2261.
5. [5] Brethauer, S.A., Aminian, A., Romero-Talamas, H., et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 258:4 (2013), 628–636 discussion 36–7.
6. [6] Iaconelli, A., Panunzi, S., De Gaetano, A., et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34:3 (2011), 561–567.
7. [7] Jackson, S., le Roux, C.W., Docherty, N.G., Bariatric surgery and microvascular complications of type 2 diabetes mellitus. Curr Atheroscler Rep, 16(11), 2014, 453.
8. [8] Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 370:21 (2014), 2002–2013.
9. [9] Saliba, J., Kasim, N.R., Tamboli, R.A., et al. Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 147:2 (2010), 282–287.
10. [10] Ritz, E., Bariatric surgery and the kidney—much benefit, but also potential harm. Clin Kidney J 6:4 (2012), 368–372.
11. [11] Morgan, D.J., Ho, K.M., Acute kidney injury in bariatric surgery patients requiring intensive care admission: a state-wide, multicenter, cohort study. Surg Obes Relat Dis 11:6 (2015), 1300–1306.
12. [12] Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 2013;28(Suppl 4), iv82-98.
13. [13] Cohen, R., Pechy, F., Petry, T., Correa, J.L., Caravatto, P.P., Tzanno-Martins, C., Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus. J Bras Nefrol 37:3 (2015), 399–409.
14. [14] Navaneethan, S.D., Yehnert, H., Moustarah, F., Schreiber, M.J., Schauer, P.R., Beddhu, S., Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4:10 (2009), 1565–1574.
15. [15] Upala S, Wijarnpreecha K, Congrete S, Rattanawong P, Sanguankeo A. Bariatric surgery reduces urinary albumin excretion in diabetic nephropathy: a systematic review and meta-analysis. Surg Obes Relat Dis. Epub 2015 Nov 26.
16. [16] Zakaria AS, Rossetti L, Cristina M, et al. Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis. Epub 2015 Nov 6.
17. [17] Miras, A.D., Chuah, L.L., Khalil, N., et al. Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study. Diabetologia 58:7 (2015), 1443–1447.
18. [18] Johnson, B.L., Blackhurst, D.W., Latham, B.B., et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 216:4 (2013), 545–556 discussion 56–8.
19. [19] Halperin, F., Ding, S.A., Simonson, D.C., et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 149:7 (2014), 716–726.
20. [20] Ikramuddin, S., Thomas, A.J., Bantle, J.P., Korner, J., Billilngton, C., Leslie, D., Impact of Roux en Y gastric bypass and intensive medical management in albuminuria: a randomized trial. Diabetes 62 (2013), A1–A98.
21. [21] Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.
22. [22] Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:4 (2009), W65–W94.
23. [23] Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. 2011 [homepage on the Internet]. The Cochrane Collaboration; 2011 [cited 2016 Jan 15]. Available from: http://handbook.cochrane.org/.
24. [24] Guyatt GH, Busse JW. Tool to assess risk of bias in randomized controlled trials [homepage on the Internet]. Evidence Partners: Ottawa, Canada; 2016 [cited 2016 Jan 15]. Available from: https://distillercer.com/resources/.
25. [25] Wells GA, Shea B, O׳Connell D, et al. University of Ottawa. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in Meta analyses [homepage on the Internet]. Ottowa, Canada: The Ottowa Hospital; 2011 [cited 2016 Jan 15]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
26. [26] Guyatt GH, Busse JW. Tool to Assess Risk of Bias in Cohort Studies [homepage on the Internet]. Evidence Partners: Ottawa, Canada; 2016 [cite 2016 Jan 15]. Available from: https://distillercer.com/resources/.
27. [27] Barendregt, J.J., Doi, S.A., Lee, Y.Y., Norman, R.E., Vos, T., Meta-analysis of prevalence. J Epidemiol Community Health 67:11 (2013), 974–978.
28. [28] Wan, X., Wang, W., Liu, J., Tong, T., Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol, 14, 2014, 135.
29. [29] Baqai, N., Graham, C., Chuah, L.L., et al. Effects of bariatric surgery on retinopathy and nephropathy in patients with type 2 diabetes. Diabet Med, 30(Suppl 2), 2013, 13.
30. [30] Hsu, C.C., Almulaifi, A., Chen, J.C., et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg 150:12 (2015), 1117–1124.
31. [31] Abbatini, F., Capoccia, D., Casella, G., Soricelli, E., Leonetti, F., Basso, N., Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis 9:4 (2013), 498–502.
32. [32] Agrawal, V., Khan, I., Rai, B., et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 70:3 (2008), 194–202.
33. [33] Aminian, A., Heneghan, H.M., Batayyah, E., et al. Effect of Roux-en-Y gastric bypass on the development and progression of diabetic nephropathy. Diabetes 62 (2013), A99–A172.
34. [34] Amor, A., Jimenez, A., Moize, V., et al. Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc 27:6 (2013), 2046–2051.
35. [35] Chuah, L.L., Mohite, A., Faruq, S., Shah, P., Miras, A., Le Roux, C., Investigation of the effects of bariatric surgery on the microvascular complications of type 2 diabetes. Diabet Med, 2012, 29.
36. [36] DePaula, A.L., Stival, A.R., Macedo, A., et al. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis 6:3 (2010), 296–304.
37. [37] DePaula, A.L., Macedo, A.L., Mota, B.R., Schraibman, V., Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 23:6 (2009), 1313–1320.
38. [38] DePaula, A.L., Stival, A.R., DePaula, C.C., Halpern, A., Vencio, S., Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg 16:5 (2012), 967–976.
39. [39] Heneghan, H.M., Cetin, D., Navaneethan, S.D., Orzech, N., Brethauer, S.A., Schauer, P.R., Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 9:1 (2013), 7–14.
40. [40] Kim, Y.J., Seo du, R., Kim, M.J., Lee, S.J., Hur, K.Y., Choi, K.S., Clinical course of diabetic retinopathy in Korean type 2 diabetes after bariatric surgery: a pilot study. Retina 35:5 (2015), 935–943.
41. [41] Kota, S.K., Ugale, S., Gupta, N., Modi, K.D., Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes. Diabetes Metab Syndr 6:3 (2012), 125–131.
42. [42] Miras, A.D., Chuah, L.L., Lascaratos, G., et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care, 35(12), 2012, e81.
43. [43] Navaneethan, S.D., Kelly, K.R., Sabbagh, F., Schauer, P.R., Kirwan, J.P., Kashyap, S.R., Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 20:3 (2010), 308–315.
44. [44] Reid, T.J., Saeed, S., McCoy, S., Osewa, A.A., Persaud, A., Ahmed, L., The effect of bariatric surgery on renal function. Surg Obes Relat Dis 10:5 (2014), 808–813.
45. [45] Stephenson, D.T., Jandeleit-Dahm, K., Balkau, B., Cohen, N., Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding. Diab Vasc Dis Res 10:6 (2013), 514–519.
46. [46] Ugale, S., Celik, A., Resolution of diabetic nephropathy following laparoscopic ileal interposition with sleeve gastrectomy in PTS with type-2 diabetes multi-center study. Obes Surg, 24, 2014, 1149.
47. [47] Zeve, J.L., Tomaz, C.A., Nassif, P.A., Lima, J.H., Sansana, L.R., Zeve, C.H., Obese patients with diabetes mellitus type 2 undergoing gastric bypass in Roux-en-Y: analysis of results and its influence in complications. Arq Bras Cir Dig 26:Suppl 1 (2013), 47–52.
48. [48] Zhang, H., Di, J., Yu, H., Han, X., Li, K., Zhang, P., The short-term remission of diabetic nephropathy after Roux-en-Y gastric bypass in chinese patients of T2 DM with obesity. Obes Surg 25:7 (2015), 1263–1270.
49. [49] Rao, B.B., Bhattacharya, A., Agrawal, V., Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease. J Nephrol 27:4 (2014), 361–370.
50. [50] Ros Ruiz, S., Diabetic nephropathy: changes after diabetes surgery?. Nutr Hosp 28:Suppl 2 (2013), 57–65.